Tekmira Up 6% On Leerink Initiation
Shares of Tekmira Pharmaceuticals (NASDAQ: TKMR) are up six percent in Monday’s pre-market trading following commentary by Leerink partners.
Leerink initiated coverage at Outperform and assigned a $25 price target.
Monday’s rally follows a 50 percent peak to trough selloff last week and 10 percent climb Friday.
Shares of Tekmira were last trading at $19.25, up 6.47 percent.
Latest Ratings for TKMR
|Jun 2015||Maxim Group||Downgrades||Buy||Hold|
|Jun 2015||Maxim Group||Downgrades||Hold|
|Nov 2014||Stifel Nicolaus||Maintains||Buy|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.